Pancreatic Cancer Research

ResearcherCharles UniversityNo recent work listed

Marek Vecka

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3269-1817; OpenAlex author ID A5039619901. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: 1 paper

Papers 4

  1. Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis. First author DOI 10.3233/cbm-160617↗
  2. Plasma fatty acid composition in patients with pancreatic cancer: correlations to clinical parameters. First author DOI 10.1080/01635581.2012.716138↗
  3. Paraoxonase-1 (PON1) status in pancreatic cancer: relation to clinical parameters. Co-author DOI 10.14712/fb2012058060231↗
  4. Leptin and adiponectin in pancreatic cancer: connection with diabetes mellitus. Co-author DOI 10.4149/neo_2011_01_58↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Aleš Žák · 4 shared papers, 2011–2016 · strength 0.15
  2. Jaroslav Macášek · 4 shared papers, 2011–2016 · strength 0.15
  3. T Krechler · 4 shared papers, 2011–2016 · strength 0.15
  4. M. Zeman · 3 shared papers, 2011–2016 · strength 0.12
  5. Jana Rychlíková · 1 shared paper, 2016 · strength 0.06
  6. Lubos B. Petruzelka · 1 shared paper, 2012 · strength 0.03
  7. Tomáš Zima · 1 shared paper, 2011 · strength 0.03
  8. Jana Kodydková · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.